Comparison

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

 

Click on the organs and learn more about cancer types

´

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

2719 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
Iladatuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5593-50mg

IchorBio
50 mg Login
Compare
Iladatuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5593-5mg

IchorBio
5 mg Login
Compare
Iladatuzumab Vedotin Biosimilar -­ Research Grade Hu FA CHO cells ICH5593V-0.1mg

IchorBio
0.1 mg Login
Compare
Iladatuzumab Vedotin Biosimilar -­ Research Grade Hu FA CHO cells ICH5593V-1mg

IchorBio
1 mg Login
Compare
Imalumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5595-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Imalumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5595-1mg

IchorBio
1 mg Login
Compare
Imalumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5595-25mg

IchorBio
25 mg Login
Compare
Imalumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5595-50mg

IchorBio
50 mg Login
Compare
Imalumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5595-5mg

IchorBio
5 mg Login
Compare
Rosmantuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5836-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Rosmantuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5836-1mg

IchorBio
1 mg Login
Compare
Rosmantuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5836-25mg

IchorBio
25 mg Login
Compare
Rosmantuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5836-50mg

IchorBio
50 mg Login
Compare
Rosmantuzumab Biosimilar -­ Research Grade Hu FA CHO cells ICH5836-5mg

IchorBio
5 mg Login
Compare
Sabirnetug Biosimilar -­ Research Grade Hu FA CHO cells ICH5842-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Sabirnetug Biosimilar -­ Research Grade Hu FA CHO cells ICH5842-1mg

IchorBio
1 mg Login
Compare
Sabirnetug Biosimilar -­ Research Grade Hu FA CHO cells ICH5842-25mg

IchorBio
25 mg Login
Compare
Sabirnetug Biosimilar -­ Research Grade Hu FA CHO cells ICH5842-50mg

IchorBio
50 mg Login
Compare
Sabirnetug Biosimilar -­ Research Grade Hu FA CHO cells ICH5842-5mg

IchorBio
5 mg Login
Compare
Semzuvolimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5851-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Semzuvolimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5851-1mg

IchorBio
1 mg Login
Compare
Semzuvolimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5851-25mg

IchorBio
25 mg Login
Compare
Semzuvolimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5851-50mg

IchorBio
50 mg Login
Compare
Semzuvolimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5851-5mg

IchorBio
5 mg Login
Compare
Serclutamab Biosimilar -­ Research Grade Hu FA CHO cells ICH5853-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Name Price
Iladatuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Iladatuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Iladatuzumab Vedotin Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 0.1 mg
Available
Iladatuzumab Vedotin Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Imalumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Imalumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Imalumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Imalumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Imalumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Rosmantuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Rosmantuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Rosmantuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Rosmantuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Rosmantuzumab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Sabirnetug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Sabirnetug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Sabirnetug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Sabirnetug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Sabirnetug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Semzuvolimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Semzuvolimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Semzuvolimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Semzuvolimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Semzuvolimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Serclutamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available

2719 Item(s)

per page